Disease ProgressionLeukemia, Lymphocytic, Chronic, B-CellRace Factors
Dr. Stanley M. Marks, MD
NPI1477524924PAC ID1052225521
- Medicare services, 2024
- 605
- Medicare patients, 2024
- 170
- Part D claims, 2024
- 760
- Publications
- 9
- Clinical trials
- 1
- Practice address
- 300 Halket Street, Pittsburgh, PA 15213
- Practice phone
- Call (412) 641-4010
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Find Dr. Marks' professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Stanley M. Marks is a hematologist and oncologist in Pittsburgh, Pennsylvania
Dr. Marks practices at UPMC Magee-Womens Hospital in Pittsburgh, Pennsylvania, part of University of Pittsburgh Medical Center.
Dr. Marks' NPI, 1477524924, was assigned on January 31, 2006. Dr. Marks graduated from University of Pittsburgh School of Medicine in 1973. Dr. Marks holds Pennsylvania license MD015807E.
NPI and contact details
- NPI
- 1477524924NPI Registry (opens in a new tab)
- Medicare PAC ID
- 1052225521
- NPI enumeration date
- January 31, 2006
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Practice phone
- (412) 641-4010
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 79
- Medical school graduation
- 1973
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Stanley M. Marks practices at UPMC Magee-Womens Hospital in Pittsburgh, Pennsylvania
Dr. Marks' primary practice is UPMC Magee-Womens Hospital, at 300 Halket Street, Pittsburgh, PA 15213 in Allegheny County. The practice phone is (412) 641-4010.
- UPMC Magee-Womens Hospital300 Halket Street, Pittsburgh, PA 15213 · Allegheny CountyPhone(412) 641-4010
Source: Dmand AI Affiliation Data
Dr. Stanley M. Marks is affiliated with 5 sites of care and 1 medical group
Dr. Marks' primary practice is UPMC Magee-Womens Hospital in Pittsburgh, Pennsylvania, part of University of Pittsburgh Medical Center. Dr. Marks is also affiliated with UPMC Presbyterian. The medical group on file is UPMC Hillman Cancer Center. Dmand AI also links Dr. Marks to 2 more hospitals and 1 group practice or clinic, each named with a free account.
UPMC PresbyterianUPMC Hillman Cancer Center2 hospitalsNames with a free account1 group practice or clinicName with a free account
See all 6 affiliations for Dr. MarksSources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Stanley M. Marks' practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Marks practices, 5 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| UPMC Magee-Womens Hospital | Available with a free account |
| +4 more affiliated sites | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
See the EHR and IT leaders at every hospital where Dr. Marks practices
Dmand AI maps EHR vendors, IT decision makers and buying committees across University of Pittsburgh Medical Center and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Stanley M. Marks is one of 645 hematologists and oncologists in Pennsylvania
Hematology and oncology is Dr. Marks' primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Marks is licensed in Pennsylvania.
Specialties and state licenses
- Hematology and oncology, PennsylvaniaPrimary
Hematologists and oncologists near Dr. Marks
Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.
645hematologists and oncologists in Pennsylvania110hematologists and oncologists in Pittsburgh42hematologists and oncologists at UPMC Magee-Womens Hospital
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Stanley M. Marks billed Medicare for 605 services in 2024
CMS data shows 605 Medicare services from Dr. Marks across 5 procedure codes in 2024, for 170 Medicare patients. Medicare paid $30,451 for them. Every service was in an office.
Medicare services, 2024605
Medicare patients170
Paid by Medicare$30,451
Procedure codes5
Dr. Marks' Medicare services by type, 2023 to 2024
- 2023
- 2024
- Office and hospital visits
- 2023: 3832024: 3557%
- Other services
- 2023: 02024: 250
Dr. Marks compared with the Pennsylvania median for hematologists and oncologists, 2024
- Dr. Marks
- Pennsylvania median
- Medicare services
- 605vs 6547% below
- Medicare patients
- 170vs 22725% below
- Part D claims
- 537vs 39337% above
Medians across 600 hematologists and oncologists in Pennsylvania with Dmand AI profiles that report each measure.
Dr. Marks' most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Marks?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Marks and other hematologists and oncologists in Pennsylvania.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Stanley M. Marks treated 170 Medicare patients in 2024, average age 76
CMS counts 170 Medicare patients who saw Dr. Marks in 2024. The largest group is 65 to 74, with 87 patients. 75% of them have high cholesterol, and 66% have high blood pressure. Their average risk score is 1.73, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Marks' median patient age at 74, with 64% women.
Medicare patients, 2024170
Average age76
Average risk score1.73
Dr. Marks' Medicare patients by age, 2024
Dr. Marks' Medicare patients by sex, 2024
- Women9858%
- Men7242%
Chronic conditions among Dr. Marks' Medicare patients, 2024
- High cholesterol75%
- High blood pressure66%
- Arthritis55%
- Cancer44%
- Ischemic heart disease31%
- Mood disorders25%
- Anxiety23%
- Depression23%
Share of Medicare patients with each condition. A patient can have several.
Dr. Marks' patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 74
Patient panel by sex, all payers
- Women64%
- Men36%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Stanley M. Marks wrote 760 Medicare Part D claims in 2024
In 2024, Dr. Marks wrote 760 Medicare Part D claims for 128 patients. 61% of them were for generic drugs. CMS names the drug for 537 of them, across 15 drugs with 11 or more claims each, at $2,509,764 in total drug cost. In 2023, CMS named 550 claims across 17 drugs.
Part D claims, 2024760
Drugs named by CMS15
Total drug cost$2.5M
Part D patients128
Dr. Marks' Part D claims by kind of drug, 2024
- Generic462 claims61%
- Brand-name298 claims39%
Dr. Marks' most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Drug classes CMS tracks in Dr. Marks' Part D claims, 2024
- Antibiotics3%19 of 760 claims
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 5502024: 5372%
Drugs named by CMS: 15 in 2024, 17 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Stanley M. Marks scored 65 out of 100 in Medicare's MIPS program for 2024
CMS publishes a Merit-based Incentive Payment System (MIPS) score of 65 out of 100 for Dr. Marks for performance year 2024, reported as part of a group. Dr. Marks accepts Medicare assignment, so Medicare's approved amount is taken as full payment.
- Accepts Medicare assignment
- Yes
Dr. Marks' MIPS scores, performance year 2024
- 65of 100Final score
- 42.5of 100Quality
- 40of 100Improvement Activities
- 76of 100Cost
Each score is out of 100. The final score weighs the categories CMS scored for this clinician.
Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026
For MedTech and pharma teams
Find hematologists and oncologists like Dr. Marks by procedure volume and prescribing
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Stanley M. Marks has 9 publications on record
Dmand AI links 9 papers to Dr. Marks, published from 2017 to 2023. 2017 was the busiest year, with 2. The most frequent topics are Antineoplastic Agents, Antibodies, Monoclonal, Humanized and Antiemetics. Dr. Marks has published most often in J Comp Eff Res. Dr. Marks' most frequent co-authors are Mounzer E. Agha, MD, Lee S. Schwartzberg, MD and Ryan Christian Augustin, MD.
Papers9
Years published2017 to 2023
Dr. Marks' papers by year, 2017 to 2023
Topics Dr. Marks writes about most
- Antineoplastic Agents
- Antibodies, Monoclonal, Humanized
- Antiemetics
- Antineoplastic Agents, Immunological
- Antineoplastic Combined Chemotherapy Protocols
- Nausea
- Palonosetron
- Vomiting
Dr. Marks' most frequent co-authors
- Mounzer E. Agha, MD2 shared papers
- Lee S. Schwartzberg, MD2 shared papers
- Ryan Christian Augustin, MD1 shared paper
Recent publications by Dr. Marks
Antibodies, Monoclonal, HumanizedAntimetabolites, AntineoplasticAntineoplastic Agents, Immunological
Antibodies, MonoclonalCosts and Cost AnalysisDrug Costs
AntiemeticsAntineoplastic AgentsInsurance Claim Review
AntiemeticsAntineoplastic AgentsBreast Neoplasms
See who Dr. Marks researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Marks works with, so you can find a warm path to the right hematologists and oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Stanley M. Marks has worked on 1 clinical trial
Dmand AI links Dr. Marks to 1 clinical trial. Conditions studied include Prostatic Neoplasms and Prostatic Diseases.
Conditions in Dr. Marks' trials
- Prostatic Neoplasms
- Prostatic Diseases
Investigators on the most trials with Dr. Marks
- Cindylou F. Connell, MD1 shared trial
- Theodore L. Crandall, MD1 shared trial
- Terry L. Evans, MD1 shared trial
Recent clinical trials with Dr. Marks
Prostatic NeoplasmsProstatic DiseasesDocetaxel
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Stanley M. Marks received $86,533 in industry payments from 2016 to 2025
CMS Open Payments shows 107 general payments to Dr. Marks from 24 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 56% of the total. AstraZeneca Pharmaceuticals LP paid the most, $21,605.
General payments to Dr. Marks by program year, 2016 to 2025
General payments to Dr. Marks by kind, 2016 to 2025
$86.5Kin total
- Consulting fees$48,23256%
- Speaker and faculty fees$23,06027%
- Food and beverage$5,0756%
- Travel and lodging$5,0136%
- Other$5,1536%
Companies that paid Dr. Marks the most, 2016 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Stanley M. Marks graduated from University of Pittsburgh School of Medicine
Dr. Marks graduated from University of Pittsburgh School of Medicine in 1973.
- Medical school
Source: Dmand AI Professional Profile Data
Sources for Dr. Stanley M. Marks's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Stanley M. Marks
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Stanley M. Marks' NPI number?
Dr. Stanley M. Marks' NPI number is 1477524924. It was assigned on January 31, 2006, and it is active in the NPI Registry.
What kind of doctor is Dr. Stanley M. Marks?
Dr. Stanley M. Marks is a hematologist and oncologist in Pittsburgh, Pennsylvania. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).
Where does Dr. Stanley M. Marks practice?
Dr. Marks practices at 300 Halket Street, Pittsburgh, PA 15213. Dr. Marks' primary practice is UPMC Magee-Womens Hospital in Pittsburgh, Pennsylvania, part of University of Pittsburgh Medical Center. Dmand AI also links Dr. Marks to 2 hospitals and 1 group practice or clinic.
What is Dr. Stanley M. Marks' office phone number?
The practice phone on file for Dr. Marks is (412) 641-4010.
What is Dr. Stanley M. Marks' medical license number?
Dr. Marks holds Pennsylvania license MD015807E.
Which hospitals is Dr. Stanley M. Marks affiliated with?
Dr. Marks practices at UPMC Magee-Womens Hospital in Pittsburgh, Pennsylvania. Dr. Marks is also affiliated with UPMC Presbyterian. Dmand AI links Dr. Marks to 2 more hospitals.
What medical group is Dr. Stanley M. Marks part of?
Dr. Marks is linked to UPMC Hillman Cancer Center.
Does Dr. Stanley M. Marks accept Medicare?
Yes. CMS data shows Dr. Marks billed Medicare for 605 services in 2024, and Dr. Marks accepts Medicare assignment.
What is Dr. Stanley M. Marks' MIPS score?
Dr. Marks' MIPS final score for performance year 2024 is 65 out of 100, reported as part of a group.
How many Medicare patients does Dr. Stanley M. Marks see?
CMS counts 170 Medicare patients who saw Dr. Marks in 2024, with an average age of 76.
Show 7 more questionsShow fewer questions
What services does Dr. Stanley M. Marks bill to Medicare?
In 2024, Dr. Marks' most billed Medicare services were medicare service (G2211), office visit, established patient (99214) and office visit, established patient (99215).
Where did Dr. Stanley M. Marks go to medical school?
Dr. Marks graduated from University of Pittsburgh School of Medicine in 1973.
What drugs does Dr. Stanley M. Marks prescribe most?
In 2024 Medicare Part D data, Dr. Marks' most prescribed drugs by claims were Letrozole, Brukinsa and Calquence.
Has Dr. Stanley M. Marks received payments from drug or device companies?
CMS Open Payments shows $86,533 in general payments to Dr. Marks from 24 companies from 2016 to 2025. The largest total came from AstraZeneca Pharmaceuticals LP.
How long has Dr. Stanley M. Marks been practicing?
Dr. Marks graduated from medical school in 1973, 53 years ago.
Does Dr. Stanley M. Marks do research?
Dmand AI links 9 publications to Dr. Marks, published from 2017 to 2023. Dr. Marks has worked on 1 clinical trial.
Who does Dr. Stanley M. Marks publish with?
Dr. Marks' most frequent co-authors are Mounzer E. Agha, MD (2 shared papers), Lee S. Schwartzberg, MD (2 shared papers) and Ryan Christian Augustin, MD (1 shared paper).
Selling to hematology and oncology practices?
See hematologists and oncologists in Pennsylvania by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card